FDA Approved: TAGRISSO — Original Application (AstraZeneca Pharmaceuticals LP)

View source ↗

Summary

The FDA approved Tagrisso (osimertinib) in an Original Application for metastatic EGFR T790M mutation-positive non-small cell lung cancer after progression on o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• TAGRISSO (osimertinib)

Snippet

ORIG AP for TAGRISSO (OSIMERTINIB)